| Document |
Document Title |
|
WO/2020/130489A1 |
The present invention relates to: a zwitterionic alginate derivative; a contrast medium composition containing the derivative; a pharmaceutical composition for preventing or treating cancer or inflammatory diseases; a method for preparin...
|
|
WO/2020/129744A1 |
An addition-curable silicone rubber composition which contains: 100 parts by mass of (A) an organopolysiloxane that has at least two alkenyl groups, each of which is bonded to a silicon atom, in each molecule, and wherein an alkenyl grou...
|
|
WO/2020/122430A1 |
The present invention provides a hyaluronic acid synthase expression system that enables the synthesis of hyaluronic acid in non-pathogenic strains and constitutive expression even in the absence of an inducing agent, a transformed strai...
|
|
WO/2020/122050A1 |
The present invention addresses the problem of providing: a novel cyclic saccharide comprising D-glucose as a constituent sugar; a novel enzyme for producing the cyclic saccharide; and production methods and uses thereof. Said problem is...
|
|
WO/2020/122429A1 |
The present invention provides a hyaluronic acid synthase mutant protein that produces hyaluronic acid at high yield in Bacillus spp. strains, which are non-pathogenic, as a result of amino acid substitution in the hyaluronic acid syntha...
|
|
WO/2020/119979A1 |
The invention relates to a xylan-containing composition (1) and to a method (100) for producing a xylan-containing composition (1), wherein acid (4) is added to an aqueous alkaline solution (2) which has hemicelluloses (3), and a xylan-c...
|
|
WO/2020/122072A1 |
A method for preparing a glycan from a glycoprotein. The method includes (I) a step in which a glycoprotein is brought into contact with a glycan isolation solution to isolate a glycan from the glycoprotein and obtain a glycan-containing...
|
|
WO/2020/116999A1 |
The present invention provides a powder-phase crosslinked hyaluronic acid, a method for producing same, a crosslinked hyaluronic acid hydrogel produced by using the powder-phase crosslinked hyaluronic acid, and a method for producing the...
|
|
WO/2020/114351A1 |
Disclosed by the present invention is a water-soluble natural polysaccharide antibacterial derivative, the molecular structure of which is shown in the following formula I: R1 is, R2 is, x, y, and n are natural numbers, 0
|
|
WO/2020/114966A1 |
The invention relates to a composition that is self-foaming in an acid medium, comprising at least: - a hydrophilic polymer, - a compound capable of cross-linking the hydrophilic polymer by the formation of ionic bonds, - a foaming agent...
|
|
WO/2020/110047A1 |
A method is provided for producing a composition comprising chitosan and water, comprising dissolving chitosan powder in an ionic liquid, to prepare a first composition comprising chitosan and ionic liquid; and contacting the first compo...
|
|
WO/2020/107820A1 |
Disclosed is a joint cavity injection preparation and a use thereof. The joint cavity injection preparation uses deacetylated xanthan gum, and has better biocompatibility and a higher safe dosage range compared with existing xanthan gum ...
|
|
WO/2020/108057A1 |
Provided is a method for preparing a modified lignin/chitosan rubber reinforcing filler, comprising the following steps: S1. purification of lignin; S2. oxidation and sulfonation of lignin; S3. complexing of lignin/chitosan; S4. synthesi...
|
|
WO/2020/109541A1 |
A process for preparation of cereal fractions. The process comprises wet milling of oat grains or barley grains in the presence of an enzyme composition derived from malt; and when oat grains or barley grains are wet milled, optionally i...
|
|
WO/2020/107710A1 |
Disclosed are a method for preparing oat beta-glucan with small and medium molecular weight and the use thereof. The preparation method comprises the step of performing enzymatic hydrolysis reaction on a substrate by using enzymes, where...
|
|
WO/2020/110007A1 |
The present disclosure provides a method of preparing a hydrogel product comprising crosslinked glycosaminoglycan molecules at a concentration Cfinal (mg/mL). The method comprising the steps of: a) crosslinking a glycosaminoglycan having...
|
|
WO/2019/143924A9 |
A therapeutic composition includes a polysaccharide, isolated from a member of the genus Cucurbita, e.g., pumpkin, having a backbone including alternating α-L-rhamnosyl (α-L-Rhap) and α-D-galactopyranosyluronic acid (α-D-GalpA) resid...
|
|
WO/2020/093849A1 |
The disclosure relates to a new type of biomimetic affinity purification material and the use thereof in purifying chitosanase, and belongs to the field of industrial biotechnology. The affinity ligand of the biomimetic affinity material...
|
|
WO/2020/093510A1 |
Disclosed by the present invention is a separation and purification method for polysaccharide in ganoderma lucidum spores, the method comprising: carrying out ultrasonic extraction on degreased ganoderma lucidum spore powder; and after f...
|
|
WO/2020/097568A2 |
Aspects of the disclosure relate to oligosaccharide compositions and methods of making the same. Also provided are methods of using oligosaccharide compositions as microbiome metabolic therapies for reducing ammonia levels and for the tr...
|
|
WO/2020/087201A1 |
A comprehensive preparation method for bamboo biological extracts and bamboo fibre, comprising: (1) preparing bamboo shavings; (2) extracting bamboo green extract and bamboo shavings polysaccharide mixed crude extract; (3) separating the...
|
|
WO/2020/085720A1 |
The present invention relates to a process for simultaneously preparing a lactic acid bacteria nucleotide and a low-molecular weight functional biomaterial having utility in industries related to skincare and cosmetics, and more specific...
|
|
WO/2020/086935A1 |
Compositions are disclosed herein comprising a graft copolymer that comprises: (i) a backbone comprising an alpha-1,3-glucan ether or ester compound, and (ii) one or more alpha-1,3-glucan side chains comprising at least about 50% alpha-1...
|
|
WO/2020/079551A1 |
The present invention describes conjugates of hyaluronic acid (HA) and an amino-bisphosphonate (N-BP) of general formula (I): Formula (I) wherein L, m, n and x are as defined in claim 1, and the salts thereof. Said conjugates and the pha...
|
|
WO/2020/080557A1 |
The purpose of the present invention is to provide a method for obtaining cellulose and/or hemicellulose from a woody material under mild conditions. This production method for cellulose and/or hemicellulose comprises subjecting a woody ...
|
|
WO/2020/073965A1 |
The present invention provides a preparation method of acetylated sodium hyaluronate, comprising the following steps: carrying out acylation reaction on hyaluronic acid or a hyaluronate in an acetic acid and acetic anhydride mixture solv...
|
|
WO/2020/075135A1 |
The present disclosure relates to the polysaccharide arabinoxylan and its use in medicine. More specifically, the present disclosure relates to arabinoxylan and its use as a biomaterial in regenerative medicine and/or tissue engineering ...
|
|
WO/2020/070267A1 |
The invention relates to a cross-linkable polymer comprising a base polymer comprising functional groups at least some of which have been reacted with a first organic molecule comprising a cross-linkable unit and with a second organic mo...
|
|
WO/2020/064811A1 |
The present invention provides a novel crystalline forms of sugammadex, designated herein as crystalline form Type 1 of sugammadex, crystalline form Type 2 of sugammadex, crystalline form Type 3 of sugammadex, crystalline form Type 8 of ...
|
|
WO/2020/066203A1 |
[Problem] To provide: a sensor which has little impact on a substance to be detected during detection, while having high detection sensitivity and wide detection dynamic range, and which changes little due to repetition of detection; and...
|
|
WO/2020/065661A1 |
Hyaluronic acid (HA) of specific molecular weight has specific applications in medical and cosmetic field. Hence, better control on HA molecular weight being produced is advantageous. The invention is for a process for production of cons...
|
|
WO/2020/061891A1 |
Disclosed are a preparation method for a composite prebiotic agent derived from citrus and use of the agent. The method comprises the following steps: blanching citrus with hot water and then peeling off citrus skin; after segmenting, so...
|
|
WO/2020/067507A1 |
A novel conjugate of a primary or secondary amine compound and an acidic polysaccharide, which is a compound represented by formula (I) (in which D, R1, R2, A, and Poly in the formula are as defined in the specification), or a pharmaceut...
|
|
WO/2020/057606A1 |
The present disclosure provides a veterinary artificial tear composition comprising a first polymer and a second polymer, wherein said first polymer and said second polymer are cross-linkable to form a hydrogel, wherein: said first polym...
|
|
WO/2020/060491A1 |
The invention relates to a compound of formula la and/or formula lb: or a pharmaceutically acceptable salt, solvate or prodrug thereof, where the groups are defined herein. The invention also relates to a pharmaceutical formulation compr...
|
|
WO/2020/058963A1 |
The invention relates to capsular polysaccharides of Streptococcus pneumoniae. More specifically, the present invention relates to sized and purified capsular polysaccharides of Streptococcus pneumoniae serotypes 2, 15A, 15C & 35B and pr...
|
|
WO/2020/057548A1 |
The present disclosure provides an eyedrop composition, comprising one or more hydrogel forming polymer having an intrinsic viscosity [η] of at least 3 dL/g in the composition, wherein a concentration CT of such hydrogel forming polymer...
|
|
WO/2020/058329A1 |
The invention relates to hydrogel particles consisting of a copolymer of at least one polysaccharide and at least one heat-sensitive polymer. The invention also relates to the use thereof for stabilising a water-in-water emulsion and to ...
|
|
WO/2020/058987A1 |
The present invention provides an improved process for the preparation of Sugammadex sodium of formula (I) having more than 98.5% purity along with less than 1.0% monohydroxy Sugammadex sodium and less than 0.15% any other known or unkno...
|
|
WO/2020/052697A1 |
The invention describes a method for the preparation of 2,3-dicarboxypolysaccharides with adjustable molecular weight, optionally modified by biologically active ligands, and their application as anticancer drug carriers. Anticancer drug...
|
|
WO/2020/049116A1 |
The invention relates to compounds, in particular based on polysaccharides that are adsorbed on a cellulosic material. The present invention relates in particular to the application of such compounds as reinforcing agent for cellulosic m...
|
|
WO/2020/050378A1 |
A compound obtained by conjugating a tertiary amine compound or imine compound useful as a drug with a polymer, the conjugate compound comprising a structure D+, which is the tertiary amine compound or imine compound D in the form of a q...
|
|
WO/2020/049166A1 |
The present invention relates to a composition comprising anethole trithione or a derivative thereof of formula (I), sulfobutyl ether-beta-cyclodextrin and optionally a co-solvent, wherein the ratio of the sulfobutyl ether-beta-cyclodext...
|
|
WO/2020/044808A1 |
Provided are a novel cyclodextrin derivative having reducing properties and a method for producing the same. The cyclodextrin derivative has a branched structure derived from an aminated α-cyclodextrin, β-cyclodextrin or γ-cyclodextri...
|
|
WO/2020/045325A1 |
The present invention provides a polyrotaxane for obtaining a material combining a higher degree of elongation with a higher breaking strength and/or a polyrotaxane having properties not possessed by conventional polyrotaxanes, such as c...
|
|
WO/2020/046964A1 |
A compound includes a polysaccharide moiety and one or more chelating agents. The one or more chelating agents are covalently bonded to the polysaccharide moiety. The polysaccharide moiety can include a glycosaminoglycan moiety, such as ...
|
|
WO/2020/039008A1 |
The invention relates to a method for lubricating a component consisting of a hydrophilic compound crosslinked by means of a water-soluble transition metal chelate.
|
|
WO/2020/037866A1 |
A low molecular weight chitooligosaccharide and a preparation method therefor, comprising the steps of dissolving chitosan in an acetate-sodium acetate buffer solution, preparing a chitosan solution, adding a compound enzyme solution int...
|
|
WO/2020/038500A1 |
The invention relates to the preparation and use of various forms comprising a derivative of hyaluronic acid - a hyaluronan chloramide, in which most of the hydrogen atoms of the amidic group -NH-CO- are replaced by chlorine atoms -NCI-C...
|
|
WO/2020/039463A1 |
Disclosed is a method of preparing N-alkylated chitosan derivatives by treating chitosan with an acid and subsequently reacting the chitosan with an alkylating agent in the presence of a base. Also provided are novel N-alkylated chitosan...
|
